CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Hearing aiddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05197803
NCT05197803N/ACompleted

Clinical Study of Released Unitron RIC (Receiver in Canal) and BTE (Behind the Ear) Hearing Aid Models

Sonova AG·interventional·Posted Jan 20, 2022·Updated May 7, 2025

In Brief

A clinical study evaluating Hearing aid for Hearing Loss. Completed, enrolled 25 participants across 1 site.

Detailed Summary

The present study will confirm the clinical benefit of 2 different released hearing aid models for speech understanding (in noise). Participants with mild to severe hearing impairment will be fit binaurally with Unitron hearing aids and will perform a standardized speech discrimination test in noise with and without hearing aids.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesCanada
CollaboratorsSonova Canada Inc.

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJan 20, 2022
Enrollment StartJan 10, 2022
Primary CompletionJan 28, 2022
TodayJul 2, 2026
Enrollment to primary: 18 daysPosted 4.5 years ago

Interventions

Hearing aiddevice

Participants will complete testing aided and unaided. The hearing aids have been fit to compensate for their hearing loss.